| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Aryl Hydrocarbon | 42 | 2024 | 221 | 13.410 |
Why?
|
| Astrocytes | 37 | 2024 | 1351 | 11.260 |
Why?
|
| Multiple Sclerosis | 49 | 2024 | 3229 | 6.720 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 32 | 2024 | 820 | 6.080 |
Why?
|
| Central Nervous System | 22 | 2023 | 1345 | 6.010 |
Why?
|
| Autoimmunity | 29 | 2023 | 1361 | 3.610 |
Why?
|
| Microglia | 12 | 2025 | 1370 | 2.830 |
Why?
|
| Apyrase | 11 | 2025 | 376 | 2.650 |
Why?
|
| Autoantibodies | 25 | 2020 | 2115 | 2.580 |
Why?
|
| Inflammation | 44 | 2024 | 10863 | 2.440 |
Why?
|
| Dendritic Cells | 16 | 2023 | 2747 | 2.380 |
Why?
|
| T-Lymphocytes, Regulatory | 30 | 2020 | 3114 | 2.320 |
Why?
|
| Autoimmune Diseases | 24 | 2023 | 2255 | 2.320 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 9 | 2021 | 1144 | 2.190 |
Why?
|
| Chaperonin 60 | 11 | 2010 | 97 | 2.090 |
Why?
|
| T-Lymphocytes | 43 | 2023 | 10263 | 2.030 |
Why?
|
| Immune Tolerance | 12 | 2023 | 2328 | 1.940 |
Why?
|
| Autoantigens | 13 | 2014 | 890 | 1.730 |
Why?
|
| Demyelinating Diseases | 4 | 2022 | 354 | 1.700 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 5 | 2023 | 627 | 1.690 |
Why?
|
| Immune System | 9 | 2021 | 800 | 1.680 |
Why?
|
| Vaccines, DNA | 10 | 2020 | 279 | 1.590 |
Why?
|
| Lymphocyte Activation | 30 | 2023 | 5502 | 1.430 |
Why?
|
| Animals | 159 | 2025 | 168939 | 1.390 |
Why?
|
| Antigens, CD | 14 | 2025 | 4033 | 1.350 |
Why?
|
| Diabetes Mellitus, Type 1 | 15 | 2016 | 3446 | 1.130 |
Why?
|
| Cell Communication | 5 | 2024 | 1660 | 1.130 |
Why?
|
| Nanoparticles | 6 | 2022 | 1966 | 1.080 |
Why?
|
| Neuroglia | 7 | 2024 | 960 | 1.070 |
Why?
|
| Th17 Cells | 10 | 2022 | 790 | 1.070 |
Why?
|
| Autoimmune Diseases of the Nervous System | 2 | 2019 | 75 | 1.050 |
Why?
|
| Neurodegenerative Diseases | 5 | 2021 | 1089 | 1.000 |
Why?
|
| Mice | 94 | 2025 | 81898 | 0.990 |
Why?
|
| Neuroimmunomodulation | 4 | 2022 | 186 | 0.950 |
Why?
|
| Environment | 4 | 2022 | 1120 | 0.940 |
Why?
|
| Interleukin-17 | 9 | 2016 | 923 | 0.940 |
Why?
|
| Mice, Inbred NOD | 17 | 2021 | 1836 | 0.920 |
Why?
|
| Antigens | 9 | 2023 | 1442 | 0.890 |
Why?
|
| Signal Transduction | 30 | 2024 | 23618 | 0.880 |
Why?
|
| Mice, Inbred C57BL | 43 | 2025 | 22351 | 0.880 |
Why?
|
| T-Lymphocyte Subsets | 13 | 2016 | 1814 | 0.870 |
Why?
|
| Adenosine Triphosphate | 6 | 2025 | 2001 | 0.850 |
Why?
|
| Arthritis, Experimental | 9 | 2007 | 293 | 0.840 |
Why?
|
| Immunity, Cellular | 5 | 2019 | 1560 | 0.820 |
Why?
|
| Myelin Sheath | 7 | 2022 | 650 | 0.810 |
Why?
|
| Adaptive Immunity | 6 | 2021 | 734 | 0.810 |
Why?
|
| Killer Cells, Natural | 4 | 2021 | 2209 | 0.810 |
Why?
|
| Autocrine Communication | 1 | 2023 | 168 | 0.790 |
Why?
|
| Biological Phenomena | 1 | 2022 | 27 | 0.790 |
Why?
|
| Intestines | 3 | 2022 | 1904 | 0.790 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 4 | 2020 | 253 | 0.790 |
Why?
|
| Herbicides | 1 | 2022 | 104 | 0.780 |
Why?
|
| Glioblastoma | 5 | 2022 | 3458 | 0.770 |
Why?
|
| Receptors, Purinergic P2Y2 | 1 | 2021 | 18 | 0.760 |
Why?
|
| Myeloid Cells | 4 | 2021 | 838 | 0.750 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 3 | 2017 | 178 | 0.750 |
Why?
|
| Brain Neoplasms | 6 | 2024 | 9101 | 0.750 |
Why?
|
| Single-Cell Analysis | 7 | 2024 | 2535 | 0.750 |
Why?
|
| Interferon-gamma | 12 | 2021 | 3157 | 0.740 |
Why?
|
| Probiotics | 2 | 2023 | 387 | 0.720 |
Why?
|
| Humans | 169 | 2024 | 766812 | 0.720 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 6 | 2022 | 551 | 0.710 |
Why?
|
| Lactic Acid | 2 | 2023 | 1139 | 0.710 |
Why?
|
| Microarray Analysis | 4 | 2014 | 751 | 0.710 |
Why?
|
| Colitis | 7 | 2024 | 1238 | 0.700 |
Why?
|
| Tryptophan | 5 | 2024 | 484 | 0.700 |
Why?
|
| MafG Transcription Factor | 1 | 2020 | 6 | 0.700 |
Why?
|
| Forkhead Transcription Factors | 8 | 2016 | 1627 | 0.690 |
Why?
|
| Insulin-Secreting Cells | 4 | 2016 | 899 | 0.680 |
Why?
|
| Phospholipases A2, Secretory | 1 | 2019 | 30 | 0.680 |
Why?
|
| Macrophages | 9 | 2021 | 5784 | 0.680 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2021 | 195 | 0.670 |
Why?
|
| Phosphatidylcholines | 2 | 2022 | 404 | 0.660 |
Why?
|
| Cytokines | 18 | 2021 | 7438 | 0.660 |
Why?
|
| Gene Expression Regulation | 13 | 2023 | 11924 | 0.640 |
Why?
|
| Coronavirus | 1 | 2021 | 155 | 0.640 |
Why?
|
| Protein Array Analysis | 4 | 2012 | 399 | 0.640 |
Why?
|
| Immunosuppressive Agents | 9 | 2020 | 4215 | 0.630 |
Why?
|
| Copper | 1 | 2021 | 365 | 0.630 |
Why?
|
| Sphingolipids | 1 | 2020 | 177 | 0.620 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2022 | 2429 | 0.610 |
Why?
|
| Kynurenine | 1 | 2019 | 142 | 0.610 |
Why?
|
| Interleukin-10 | 16 | 2020 | 1182 | 0.610 |
Why?
|
| Zebrafish | 5 | 2022 | 3035 | 0.600 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 4 | 2021 | 975 | 0.600 |
Why?
|
| Immunoglobulin G | 13 | 2020 | 4559 | 0.600 |
Why?
|
| Epitopes, T-Lymphocyte | 6 | 2020 | 827 | 0.590 |
Why?
|
| Quinolones | 1 | 2021 | 389 | 0.560 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2023 | 789 | 0.540 |
Why?
|
| Genes, Reporter | 2 | 2018 | 1525 | 0.520 |
Why?
|
| Indoles | 7 | 2021 | 1834 | 0.520 |
Why?
|
| Blood-Brain Barrier | 4 | 2022 | 1028 | 0.520 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2017 | 121 | 0.520 |
Why?
|
| Monocytes | 5 | 2019 | 2599 | 0.510 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2015 | 129 | 0.500 |
Why?
|
| Immunity, Innate | 11 | 2021 | 3079 | 0.500 |
Why?
|
| Heat-Shock Proteins | 5 | 2020 | 792 | 0.490 |
Why?
|
| Brain | 16 | 2024 | 27158 | 0.490 |
Why?
|
| Biological Assay | 1 | 2018 | 626 | 0.480 |
Why?
|
| Central Nervous System Diseases | 2 | 2020 | 518 | 0.470 |
Why?
|
| Lupus Erythematosus, Systemic | 6 | 2020 | 2160 | 0.470 |
Why?
|
| Lipopolysaccharides | 3 | 2016 | 2215 | 0.470 |
Why?
|
| Rheumatic Fever | 1 | 2014 | 73 | 0.460 |
Why?
|
| Cell Differentiation | 19 | 2020 | 11657 | 0.460 |
Why?
|
| CD4-Positive T-Lymphocytes | 10 | 2023 | 4410 | 0.460 |
Why?
|
| Nervous System Diseases | 2 | 2022 | 1659 | 0.450 |
Why?
|
| Immunity | 5 | 2022 | 1002 | 0.450 |
Why?
|
| Melatonin | 2 | 2016 | 670 | 0.450 |
Why?
|
| Synapses | 1 | 2023 | 1759 | 0.450 |
Why?
|
| Ligands | 10 | 2021 | 3274 | 0.440 |
Why?
|
| Glycolipids | 1 | 2014 | 203 | 0.440 |
Why?
|
| Interferon Type I | 2 | 2023 | 568 | 0.430 |
Why?
|
| Antigen-Presenting Cells | 3 | 2014 | 960 | 0.430 |
Why?
|
| Galactosyltransferases | 1 | 2014 | 283 | 0.410 |
Why?
|
| Nerve Degeneration | 2 | 2014 | 748 | 0.410 |
Why?
|
| Drug Delivery Systems | 2 | 2021 | 2210 | 0.410 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 4 | 2016 | 812 | 0.410 |
Why?
|
| B-Lymphocytes | 10 | 2023 | 4787 | 0.400 |
Why?
|
| Thiazoles | 5 | 2020 | 1529 | 0.400 |
Why?
|
| Mice, Knockout | 20 | 2025 | 14473 | 0.400 |
Why?
|
| Virus Replication | 1 | 2020 | 2457 | 0.400 |
Why?
|
| Epitopes | 3 | 2014 | 2526 | 0.400 |
Why?
|
| Cells, Cultured | 20 | 2019 | 18986 | 0.370 |
Why?
|
| Membrane Lipids | 1 | 2012 | 241 | 0.370 |
Why?
|
| Adjuvants, Immunologic | 6 | 2007 | 996 | 0.370 |
Why?
|
| Interleukins | 3 | 2014 | 796 | 0.350 |
Why?
|
| Immunoglobulin M | 8 | 2022 | 1527 | 0.350 |
Why?
|
| 5'-Nucleotidase | 4 | 2020 | 163 | 0.350 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2021 | 2678 | 0.350 |
Why?
|
| Vascular Endothelial Growth Factor B | 2 | 2021 | 25 | 0.350 |
Why?
|
| CD8-Positive T-Lymphocytes | 5 | 2022 | 4652 | 0.350 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2020 | 393 | 0.350 |
Why?
|
| Nanotechnology | 2 | 2013 | 702 | 0.340 |
Why?
|
| Membrane Proteins | 3 | 2024 | 7869 | 0.340 |
Why?
|
| Transforming Growth Factor alpha | 2 | 2021 | 134 | 0.340 |
Why?
|
| Chagas Disease | 2 | 2024 | 166 | 0.330 |
Why?
|
| Genetic Testing | 1 | 2023 | 3591 | 0.330 |
Why?
|
| Glioma | 2 | 2021 | 3498 | 0.330 |
Why?
|
| Feedback, Physiological | 2 | 2023 | 481 | 0.330 |
Why?
|
| NF-kappa B | 4 | 2022 | 2493 | 0.320 |
Why?
|
| Tumor Microenvironment | 6 | 2024 | 3942 | 0.320 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 2902 | 0.320 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2024 | 1805 | 0.320 |
Why?
|
| Receptors, Cholinergic | 2 | 2016 | 243 | 0.320 |
Why?
|
| Repressor Proteins | 1 | 2020 | 2979 | 0.320 |
Why?
|
| Microfluidics | 3 | 2023 | 650 | 0.310 |
Why?
|
| Rats, Inbred Lew | 11 | 2008 | 1168 | 0.300 |
Why?
|
| Hep G2 Cells | 2 | 2020 | 378 | 0.300 |
Why?
|
| Antiviral Agents | 1 | 2021 | 3070 | 0.300 |
Why?
|
| Zebrafish Proteins | 2 | 2016 | 1018 | 0.300 |
Why?
|
| Lactosylceramides | 2 | 2020 | 15 | 0.300 |
Why?
|
| Oligodendroglia | 3 | 2022 | 539 | 0.300 |
Why?
|
| Glutamic Acid | 3 | 2024 | 1181 | 0.300 |
Why?
|
| Adenosine | 3 | 2025 | 812 | 0.290 |
Why?
|
| Peptide Fragments | 8 | 2020 | 5143 | 0.290 |
Why?
|
| Shock, Septic | 1 | 2014 | 772 | 0.290 |
Why?
|
| Disease Models, Animal | 13 | 2024 | 18329 | 0.290 |
Why?
|
| Models, Immunological | 4 | 2019 | 517 | 0.290 |
Why?
|
| Female | 70 | 2025 | 396532 | 0.280 |
Why?
|
| Disease Progression | 9 | 2020 | 13642 | 0.280 |
Why?
|
| Interleukin-6 | 2 | 2016 | 3226 | 0.280 |
Why?
|
| Th1 Cells | 7 | 2019 | 1040 | 0.280 |
Why?
|
| STAT3 Transcription Factor | 3 | 2019 | 872 | 0.280 |
Why?
|
| HIV Envelope Protein gp41 | 2 | 2006 | 306 | 0.270 |
Why?
|
| Receptors, Adrenergic, beta-2 | 2 | 2019 | 216 | 0.270 |
Why?
|
| Sphingosine | 2 | 2020 | 306 | 0.270 |
Why?
|
| Up-Regulation | 5 | 2014 | 4143 | 0.260 |
Why?
|
| Muromonab-CD3 | 3 | 2022 | 104 | 0.260 |
Why?
|
| STAT1 Transcription Factor | 2 | 2019 | 340 | 0.260 |
Why?
|
| Transforming Growth Factor beta1 | 4 | 2016 | 637 | 0.260 |
Why?
|
| Bacterial Proteins | 4 | 2021 | 3833 | 0.260 |
Why?
|
| Interleukin-2 | 2 | 2012 | 1895 | 0.260 |
Why?
|
| Receptors, Interleukin-10 | 2 | 2016 | 49 | 0.250 |
Why?
|
| Systems Biology | 2 | 2009 | 481 | 0.250 |
Why?
|
| Trans-Activators | 2 | 2012 | 2856 | 0.240 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2008 | 588 | 0.240 |
Why?
|
| Nucleotide Transport Proteins | 1 | 2024 | 5 | 0.240 |
Why?
|
| Peptides | 3 | 2013 | 4347 | 0.240 |
Why?
|
| Histidine Decarboxylase | 1 | 2004 | 12 | 0.240 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2024 | 21 | 0.230 |
Why?
|
| Reactive Oxygen Species | 2 | 2023 | 2144 | 0.230 |
Why?
|
| Immunologic Techniques | 1 | 2004 | 212 | 0.230 |
Why?
|
| Antibody Formation | 3 | 2020 | 1392 | 0.230 |
Why?
|
| Fibrinogen | 2 | 2020 | 893 | 0.230 |
Why?
|
| Acetyl Coenzyme A | 1 | 2024 | 74 | 0.220 |
Why?
|
| Chemokine CCL2 | 3 | 2016 | 605 | 0.220 |
Why?
|
| Transposases | 1 | 2024 | 106 | 0.220 |
Why?
|
| Coronavirus Infections | 1 | 2021 | 3110 | 0.220 |
Why?
|
| Sequence Analysis, RNA | 3 | 2020 | 2039 | 0.220 |
Why?
|
| Chagas Cardiomyopathy | 1 | 2024 | 72 | 0.210 |
Why?
|
| Neural Stem Cells | 2 | 2022 | 895 | 0.210 |
Why?
|
| Myasthenia Gravis, Autoimmune, Experimental | 1 | 2003 | 7 | 0.210 |
Why?
|
| Lactase | 1 | 2023 | 72 | 0.210 |
Why?
|
| Receptors, Immunologic | 3 | 2020 | 1417 | 0.210 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2016 | 564 | 0.210 |
Why?
|
| Inflammasomes | 3 | 2020 | 541 | 0.210 |
Why?
|
| Computational Biology | 4 | 2019 | 3564 | 0.210 |
Why?
|
| Mice, Transgenic | 8 | 2020 | 9546 | 0.210 |
Why?
|
| High-Throughput Screening Assays | 2 | 2023 | 938 | 0.210 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 9 | 2020 | 3803 | 0.210 |
Why?
|
| Gene Expression | 4 | 2023 | 7585 | 0.200 |
Why?
|
| Male | 45 | 2025 | 364154 | 0.200 |
Why?
|
| Amino Acid Sequence | 10 | 2021 | 13411 | 0.200 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2022 | 102 | 0.200 |
Why?
|
| Antigen Presentation | 3 | 2023 | 1250 | 0.200 |
Why?
|
| Phagocytes | 2 | 2021 | 292 | 0.200 |
Why?
|
| Cell Physiological Phenomena | 1 | 2023 | 149 | 0.190 |
Why?
|
| Nerve Tissue Proteins | 5 | 2021 | 4401 | 0.190 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2004 | 422 | 0.190 |
Why?
|
| Nucleus Accumbens | 1 | 2024 | 360 | 0.190 |
Why?
|
| Receptor, EphB3 | 1 | 2021 | 11 | 0.190 |
Why?
|
| Ephrin-B3 | 1 | 2021 | 12 | 0.190 |
Why?
|
| Vaccination | 5 | 2014 | 3435 | 0.190 |
Why?
|
| Antigen-Antibody Reactions | 2 | 2012 | 341 | 0.190 |
Why?
|
| Herpesvirus 1, Suid | 1 | 2021 | 25 | 0.180 |
Why?
|
| Injections, Intramuscular | 4 | 2003 | 551 | 0.180 |
Why?
|
| Foot Ulcer | 1 | 2021 | 62 | 0.180 |
Why?
|
| Rats | 15 | 2008 | 23717 | 0.180 |
Why?
|
| Semaphorins | 1 | 2021 | 96 | 0.180 |
Why?
|
| Gene Knockdown Techniques | 2 | 2016 | 1604 | 0.180 |
Why?
|
| Oligopeptides | 1 | 2006 | 1195 | 0.180 |
Why?
|
| Interferon-beta | 3 | 2022 | 348 | 0.180 |
Why?
|
| Antibodies, Monoclonal | 5 | 2022 | 9244 | 0.180 |
Why?
|
| Maleimides | 1 | 2021 | 112 | 0.180 |
Why?
|
| Vitamins | 1 | 2009 | 1631 | 0.180 |
Why?
|
| Demyelinating Autoimmune Diseases, CNS | 1 | 2020 | 40 | 0.180 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2023 | 434 | 0.180 |
Why?
|
| Congresses as Topic | 2 | 2024 | 811 | 0.180 |
Why?
|
| Cyclophosphamide | 3 | 2007 | 2234 | 0.170 |
Why?
|
| Bystander Effect | 1 | 2020 | 89 | 0.170 |
Why?
|
| Methionine Adenosyltransferase | 1 | 2020 | 16 | 0.170 |
Why?
|
| Models, Animal | 1 | 2007 | 2121 | 0.170 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2006 | 2571 | 0.170 |
Why?
|
| Antibodies, Antinuclear | 2 | 2020 | 340 | 0.170 |
Why?
|
| 1-Deoxynojirimycin | 1 | 2019 | 19 | 0.170 |
Why?
|
| Nucleic Acids | 1 | 2023 | 189 | 0.170 |
Why?
|
| Larva | 1 | 2022 | 511 | 0.170 |
Why?
|
| Neurosciences | 1 | 2024 | 384 | 0.170 |
Why?
|
| Virus Latency | 1 | 2023 | 359 | 0.170 |
Why?
|
| Trypanosoma cruzi | 2 | 2019 | 204 | 0.170 |
Why?
|
| Adoptive Transfer | 5 | 2014 | 828 | 0.170 |
Why?
|
| Gangliosides | 1 | 2020 | 132 | 0.170 |
Why?
|
| Neuroprotective Agents | 1 | 2006 | 956 | 0.170 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2024 | 632 | 0.160 |
Why?
|
| Genomics | 4 | 2024 | 5922 | 0.160 |
Why?
|
| Linuron | 1 | 2019 | 4 | 0.160 |
Why?
|
| Hexokinase | 1 | 2019 | 125 | 0.160 |
Why?
|
| Synthetic Biology | 1 | 2021 | 188 | 0.160 |
Why?
|
| Yolk Sac | 1 | 2019 | 79 | 0.160 |
Why?
|
| Plasmids | 2 | 2003 | 2268 | 0.160 |
Why?
|
| Vero Cells | 1 | 2020 | 486 | 0.160 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2000 | 705 | 0.160 |
Why?
|
| Chaperonins | 3 | 2004 | 58 | 0.160 |
Why?
|
| Cell Proliferation | 10 | 2023 | 10451 | 0.160 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2019 | 43 | 0.160 |
Why?
|
| Meninges | 1 | 2021 | 197 | 0.160 |
Why?
|
| Gastrointestinal Tract | 2 | 2024 | 835 | 0.160 |
Why?
|
| Adenosine Monophosphate | 2 | 2020 | 232 | 0.160 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2021 | 447 | 0.160 |
Why?
|
| Chromatin | 2 | 2024 | 2980 | 0.160 |
Why?
|
| Receptors, sigma | 1 | 2019 | 46 | 0.160 |
Why?
|
| Epididymis | 1 | 2020 | 227 | 0.150 |
Why?
|
| Activins | 1 | 2020 | 211 | 0.150 |
Why?
|
| Nerve Regeneration | 1 | 2024 | 796 | 0.150 |
Why?
|
| Cell Line, Tumor | 8 | 2021 | 17089 | 0.150 |
Why?
|
| Research Report | 1 | 2021 | 367 | 0.150 |
Why?
|
| Gene Expression Profiling | 6 | 2024 | 9528 | 0.150 |
Why?
|
| Steroids | 1 | 2023 | 936 | 0.150 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2018 | 105 | 0.150 |
Why?
|
| Transcription, Genetic | 3 | 2020 | 7612 | 0.150 |
Why?
|
| Lysophospholipids | 1 | 2020 | 336 | 0.150 |
Why?
|
| Colitis, Ulcerative | 2 | 2024 | 1920 | 0.150 |
Why?
|
| Neoplasms | 2 | 2017 | 22350 | 0.140 |
Why?
|
| Reward | 1 | 2024 | 980 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 2 | 2020 | 4780 | 0.140 |
Why?
|
| Protein Engineering | 1 | 2021 | 554 | 0.140 |
Why?
|
| Viruses | 1 | 2021 | 371 | 0.140 |
Why?
|
| MicroRNAs | 3 | 2019 | 3789 | 0.140 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2020 | 382 | 0.140 |
Why?
|
| Endoribonucleases | 1 | 2019 | 230 | 0.140 |
Why?
|
| Diabetic Foot | 1 | 2021 | 382 | 0.140 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2016 | 65 | 0.140 |
Why?
|
| DNA | 3 | 2021 | 7210 | 0.140 |
Why?
|
| Liposomes | 1 | 2020 | 787 | 0.140 |
Why?
|
| Nasal Mucosa | 2 | 2011 | 416 | 0.140 |
Why?
|
| Lectins | 1 | 2019 | 490 | 0.140 |
Why?
|
| Tryptophanase | 1 | 2016 | 6 | 0.130 |
Why?
|
| Sympathetic Nervous System | 1 | 2019 | 520 | 0.130 |
Why?
|
| Indican | 1 | 2016 | 16 | 0.130 |
Why?
|
| HIV-1 | 2 | 2023 | 6948 | 0.130 |
Why?
|
| Neural Inhibition | 1 | 2020 | 589 | 0.130 |
Why?
|
| Immunologic Memory | 4 | 2023 | 1377 | 0.130 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2020 | 892 | 0.130 |
Why?
|
| Perforin | 1 | 2016 | 167 | 0.130 |
Why?
|
| Dermatitis, Atopic | 1 | 2023 | 734 | 0.130 |
Why?
|
| Immunoglobulins | 3 | 2009 | 853 | 0.130 |
Why?
|
| Receptors, Purinergic | 1 | 2016 | 66 | 0.130 |
Why?
|
| CpG Islands | 1 | 2000 | 1208 | 0.130 |
Why?
|
| Mouth Neoplasms | 1 | 2021 | 597 | 0.130 |
Why?
|
| Genetic Engineering | 1 | 2021 | 936 | 0.130 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2016 | 113 | 0.130 |
Why?
|
| Psoriasis | 1 | 2023 | 925 | 0.130 |
Why?
|
| Symbiosis | 1 | 2018 | 297 | 0.130 |
Why?
|
| Malnutrition | 1 | 2022 | 629 | 0.130 |
Why?
|
| Organ Specificity | 1 | 2020 | 1968 | 0.120 |
Why?
|
| Down-Regulation | 4 | 2012 | 2931 | 0.120 |
Why?
|
| Antigens, Ly | 2 | 2021 | 297 | 0.120 |
Why?
|
| Oxygen Consumption | 1 | 2021 | 1874 | 0.120 |
Why?
|
| Endodeoxyribonucleases | 1 | 2016 | 165 | 0.120 |
Why?
|
| HEK293 Cells | 3 | 2020 | 4277 | 0.120 |
Why?
|
| Calmodulin | 1 | 2016 | 239 | 0.120 |
Why?
|
| Parturition | 2 | 2011 | 453 | 0.120 |
Why?
|
| Leptin | 2 | 2014 | 1596 | 0.120 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2019 | 1352 | 0.120 |
Why?
|
| Virus Internalization | 1 | 2019 | 504 | 0.120 |
Why?
|
| Virus Diseases | 1 | 2021 | 721 | 0.120 |
Why?
|
| Sirtuins | 1 | 2017 | 322 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2018 | 559 | 0.120 |
Why?
|
| Transplantation, Heterologous | 2 | 2021 | 2391 | 0.120 |
Why?
|
| Cerebrovascular Circulation | 1 | 2025 | 2671 | 0.120 |
Why?
|
| Cell-Derived Microparticles | 1 | 2016 | 159 | 0.120 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2016 | 513 | 0.120 |
Why?
|
| Immunoglobulin Isotypes | 3 | 2011 | 158 | 0.120 |
Why?
|
| Cell Lineage | 2 | 2016 | 2573 | 0.120 |
Why?
|
| Motivation | 1 | 2024 | 2020 | 0.120 |
Why?
|
| Drug Combinations | 1 | 2020 | 2085 | 0.110 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2016 | 1529 | 0.110 |
Why?
|
| Fibrosis | 1 | 2021 | 2078 | 0.110 |
Why?
|
| Growth Inhibitors | 2 | 2008 | 375 | 0.110 |
Why?
|
| Protein Kinases | 1 | 2021 | 1610 | 0.110 |
Why?
|
| Crohn Disease | 2 | 2018 | 2286 | 0.110 |
Why?
|
| Mice, Inbred NZB | 3 | 2020 | 57 | 0.110 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2024 | 3667 | 0.110 |
Why?
|
| Sample Size | 1 | 2017 | 844 | 0.110 |
Why?
|
| Organ Transplantation | 1 | 2023 | 1172 | 0.110 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2016 | 1442 | 0.110 |
Why?
|
| Peptoids | 1 | 2013 | 7 | 0.110 |
Why?
|
| Anticipation, Psychological | 1 | 2014 | 90 | 0.110 |
Why?
|
| Carrier Proteins | 4 | 2013 | 4926 | 0.110 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2016 | 857 | 0.110 |
Why?
|
| Social Identification | 1 | 2014 | 108 | 0.110 |
Why?
|
| Molecular Sequence Data | 7 | 2010 | 17609 | 0.110 |
Why?
|
| Flow Cytometry | 6 | 2024 | 5890 | 0.110 |
Why?
|
| Norepinephrine | 1 | 2015 | 898 | 0.100 |
Why?
|
| Cell Compartmentation | 2 | 2010 | 383 | 0.100 |
Why?
|
| Interleukin-1beta | 2 | 2016 | 1026 | 0.100 |
Why?
|
| Body Fluids | 1 | 2014 | 321 | 0.100 |
Why?
|
| Immunoblotting | 1 | 2016 | 1647 | 0.100 |
Why?
|
| Spinal Cord | 1 | 2021 | 1811 | 0.100 |
Why?
|
| Receptors, Cytokine | 1 | 2013 | 258 | 0.100 |
Why?
|
| Environmental Exposure | 2 | 2019 | 4544 | 0.100 |
Why?
|
| Glutamate Decarboxylase | 2 | 2004 | 239 | 0.100 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2012 | 44 | 0.100 |
Why?
|
| Histamine | 2 | 2004 | 496 | 0.100 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2014 | 271 | 0.100 |
Why?
|
| Pregnancy Proteins | 2 | 2004 | 222 | 0.100 |
Why?
|
| Receptors, Interleukin | 1 | 2013 | 243 | 0.100 |
Why?
|
| Microsomes, Liver | 1 | 2012 | 174 | 0.100 |
Why?
|
| Oligoclonal Bands | 1 | 2012 | 17 | 0.100 |
Why?
|
| Hypersensitivity, Delayed | 3 | 2011 | 491 | 0.100 |
Why?
|
| Models, Neurological | 1 | 2020 | 1747 | 0.100 |
Why?
|
| Homeostasis | 2 | 2021 | 3343 | 0.100 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2016 | 1044 | 0.100 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2012 | 86 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2021 | 2060 | 0.100 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2012 | 62 | 0.100 |
Why?
|
| Antioxidants | 1 | 2020 | 1671 | 0.100 |
Why?
|
| Melanoma | 2 | 2023 | 5702 | 0.100 |
Why?
|
| Receptors, CCR | 1 | 2011 | 37 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 5 | 2012 | 3759 | 0.100 |
Why?
|
| Dogs | 1 | 2016 | 3834 | 0.100 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 1895 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 2470 | 0.100 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 2815 | 0.100 |
Why?
|
| Osteopontin | 1 | 2013 | 305 | 0.090 |
Why?
|
| Administration, Intranasal | 3 | 2022 | 482 | 0.090 |
Why?
|
| Hypersensitivity | 1 | 2021 | 1168 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 6 | 2010 | 6225 | 0.090 |
Why?
|
| Sepsis | 1 | 2005 | 2604 | 0.090 |
Why?
|
| Serotonin | 1 | 2016 | 1045 | 0.090 |
Why?
|
| MAP Kinase Signaling System | 3 | 2019 | 1492 | 0.090 |
Why?
|
| Adult | 24 | 2022 | 223305 | 0.090 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2015 | 549 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 2 | 2014 | 5795 | 0.090 |
Why?
|
| Oncogene Protein v-maf | 1 | 2010 | 5 | 0.090 |
Why?
|
| Anxiety | 2 | 2024 | 4668 | 0.090 |
Why?
|
| Th2 Cells | 3 | 2012 | 1077 | 0.090 |
Why?
|
| Ikaros Transcription Factor | 1 | 2012 | 233 | 0.090 |
Why?
|
| Genome | 1 | 2019 | 1753 | 0.090 |
Why?
|
| Ferritins | 2 | 2004 | 601 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 685 | 0.090 |
Why?
|
| Homeodomain Proteins | 3 | 2016 | 2429 | 0.090 |
Why?
|
| Apoptosis | 2 | 2021 | 9514 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2021 | 3723 | 0.090 |
Why?
|
| Transfection | 1 | 2018 | 5755 | 0.090 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2021 | 1664 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 4 | 2019 | 1996 | 0.080 |
Why?
|
| Receptors, Vasoactive Intestinal Peptide, Type II | 1 | 2009 | 7 | 0.080 |
Why?
|
| Diet | 2 | 2019 | 8088 | 0.080 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2010 | 71 | 0.080 |
Why?
|
| Cell Migration Inhibition | 1 | 2009 | 97 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2021 | 3698 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 2 | 2016 | 6066 | 0.080 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2014 | 746 | 0.080 |
Why?
|
| Sodium | 1 | 2014 | 1594 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcr | 1 | 2008 | 21 | 0.080 |
Why?
|
| Epigenesis, Genetic | 2 | 2024 | 3828 | 0.080 |
Why?
|
| Neoplasm Metastasis | 2 | 2017 | 4892 | 0.080 |
Why?
|
| Environmental Pollutants | 1 | 2018 | 1292 | 0.080 |
Why?
|
| Immunotherapy | 4 | 2021 | 4747 | 0.080 |
Why?
|
| Diabetic Retinopathy | 1 | 2017 | 1300 | 0.070 |
Why?
|
| Antibodies | 2 | 2013 | 2421 | 0.070 |
Why?
|
| Mitochondria | 1 | 2021 | 3678 | 0.070 |
Why?
|
| Tretinoin | 1 | 2010 | 524 | 0.070 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2009 | 428 | 0.070 |
Why?
|
| HIV Infections | 2 | 2023 | 17532 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 2823 | 0.070 |
Why?
|
| Serum | 1 | 2008 | 206 | 0.070 |
Why?
|
| Social Stigma | 1 | 2014 | 788 | 0.070 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 2009 | 661 | 0.070 |
Why?
|
| Mice, Inbred C3H | 1 | 2008 | 915 | 0.070 |
Why?
|
| Galectins | 1 | 2010 | 295 | 0.070 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2009 | 347 | 0.070 |
Why?
|
| Tropomyosin | 1 | 2007 | 105 | 0.070 |
Why?
|
| Integrins | 1 | 2011 | 839 | 0.070 |
Why?
|
| Immunologic Factors | 1 | 2016 | 1594 | 0.070 |
Why?
|
| Databases, Factual | 1 | 2022 | 8065 | 0.070 |
Why?
|
| ROC Curve | 1 | 2014 | 3621 | 0.070 |
Why?
|
| Receptors, Virus | 1 | 2010 | 652 | 0.070 |
Why?
|
| Conserved Sequence | 1 | 2010 | 1159 | 0.070 |
Why?
|
| Spleen | 5 | 2010 | 2295 | 0.070 |
Why?
|
| Behcet Syndrome | 1 | 2007 | 86 | 0.070 |
Why?
|
| Cell Line | 5 | 2009 | 15564 | 0.070 |
Why?
|
| Carbazoles | 1 | 2008 | 230 | 0.070 |
Why?
|
| Depression | 2 | 2024 | 8225 | 0.070 |
Why?
|
| Toll-Like Receptors | 1 | 2009 | 582 | 0.060 |
Why?
|
| Immunophenotyping | 4 | 2015 | 1867 | 0.060 |
Why?
|
| Receptors, Interleukin-2 | 2 | 2004 | 565 | 0.060 |
Why?
|
| Hematopoiesis | 1 | 2015 | 2060 | 0.060 |
Why?
|
| Cohort Studies | 5 | 2020 | 41706 | 0.060 |
Why?
|
| Exons | 1 | 2011 | 2392 | 0.060 |
Why?
|
| Middle Aged | 16 | 2021 | 223267 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2010 | 2746 | 0.060 |
Why?
|
| Ionomycin | 1 | 2005 | 109 | 0.060 |
Why?
|
| DNA Methylation | 1 | 2020 | 4427 | 0.060 |
Why?
|
| Proteomics | 3 | 2024 | 3915 | 0.060 |
Why?
|
| Emotions | 1 | 2017 | 2758 | 0.060 |
Why?
|
| Ionophores | 1 | 2005 | 108 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2021 | 4050 | 0.060 |
Why?
|
| Oxygen | 1 | 2017 | 4252 | 0.060 |
Why?
|
| Aging | 2 | 2021 | 8728 | 0.060 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2015 | 1481 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 2016 | 12795 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 874 | 0.060 |
Why?
|
| Immunomodulation | 2 | 2020 | 548 | 0.060 |
Why?
|
| Receptors, Purinergic P2Y12 | 1 | 2025 | 117 | 0.060 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2006 | 354 | 0.060 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2008 | 582 | 0.060 |
Why?
|
| Vibrissae | 1 | 2025 | 121 | 0.060 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2005 | 826 | 0.060 |
Why?
|
| Neoplasms, Experimental | 1 | 2009 | 1228 | 0.060 |
Why?
|
| Structure-Activity Relationship | 2 | 2021 | 3053 | 0.060 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2024 | 88 | 0.060 |
Why?
|
| Resorcinols | 1 | 2023 | 41 | 0.060 |
Why?
|
| Infant, Newborn | 6 | 2022 | 26387 | 0.060 |
Why?
|
| Membrane Fusion | 1 | 2005 | 265 | 0.060 |
Why?
|
| Placentation | 1 | 2004 | 78 | 0.050 |
Why?
|
| Atrophy | 3 | 2019 | 1631 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2007 | 2551 | 0.050 |
Why?
|
| Pregnancy, Animal | 1 | 2004 | 124 | 0.050 |
Why?
|
| Eosinophils | 2 | 2021 | 952 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 8715 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 1 | 2004 | 420 | 0.050 |
Why?
|
| Carcinogens | 1 | 2005 | 452 | 0.050 |
Why?
|
| Stilbenes | 1 | 2023 | 155 | 0.050 |
Why?
|
| Exocytosis | 1 | 2024 | 323 | 0.050 |
Why?
|
| Uterus | 1 | 2007 | 661 | 0.050 |
Why?
|
| Interleukin-23 | 2 | 2016 | 202 | 0.050 |
Why?
|
| Proteome | 1 | 2013 | 1894 | 0.050 |
Why?
|
| Longitudinal Studies | 5 | 2020 | 14762 | 0.050 |
Why?
|
| Cross Reactions | 1 | 2004 | 826 | 0.050 |
Why?
|
| Lung | 1 | 2021 | 10068 | 0.050 |
Why?
|
| Muscle Proteins | 1 | 2007 | 1160 | 0.050 |
Why?
|
| Immunodominant Epitopes | 1 | 2003 | 244 | 0.050 |
Why?
|
| Graft Survival | 1 | 2012 | 3904 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2016 | 22248 | 0.050 |
Why?
|
| Lateral Ventricles | 1 | 2022 | 142 | 0.050 |
Why?
|
| Neurons | 1 | 2020 | 9515 | 0.050 |
Why?
|
| Mycobacterium | 1 | 2002 | 252 | 0.050 |
Why?
|
| Receptor, Adenosine A1 | 1 | 2020 | 42 | 0.050 |
Why?
|
| Neovascularization, Pathologic | 2 | 2017 | 2631 | 0.050 |
Why?
|
| Common Bile Duct | 1 | 2001 | 106 | 0.040 |
Why?
|
| Fibroblasts | 2 | 2024 | 4166 | 0.040 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2020 | 37 | 0.040 |
Why?
|
| Dioxins | 1 | 2021 | 91 | 0.040 |
Why?
|
| Research Subjects | 1 | 2022 | 248 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2020 | 6869 | 0.040 |
Why?
|
| Immunity, Mucosal | 2 | 2016 | 498 | 0.040 |
Why?
|
| Mice, SCID | 2 | 2021 | 2626 | 0.040 |
Why?
|
| Cerebrovascular Disorders | 3 | 1995 | 1478 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 4570 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2011 | 3041 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2017 | 3511 | 0.040 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2023 | 546 | 0.040 |
Why?
|
| Axons | 1 | 2008 | 1675 | 0.040 |
Why?
|
| Models, Molecular | 3 | 2021 | 5388 | 0.040 |
Why?
|
| Melanoma, Experimental | 1 | 2023 | 557 | 0.040 |
Why?
|
| Cell Survival | 2 | 2023 | 5749 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2021 | 540 | 0.040 |
Why?
|
| Cholesterol | 1 | 2008 | 2904 | 0.040 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2021 | 432 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2020 | 36570 | 0.040 |
Why?
|
| Immunization Schedule | 1 | 2000 | 229 | 0.040 |
Why?
|
| Hexosaminidases | 1 | 2019 | 45 | 0.040 |
Why?
|
| Antigens, Bacterial | 1 | 2004 | 1148 | 0.040 |
Why?
|
| Follow-Up Studies | 4 | 2017 | 39312 | 0.040 |
Why?
|
| Young Adult | 4 | 2020 | 59939 | 0.040 |
Why?
|
| Pancreatic Ducts | 1 | 2001 | 330 | 0.040 |
Why?
|
| Uveitis | 1 | 2003 | 398 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2018 | 3427 | 0.040 |
Why?
|
| Aged | 6 | 2020 | 171344 | 0.040 |
Why?
|
| Protein Binding | 3 | 2018 | 9326 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2014 | 4526 | 0.040 |
Why?
|
| GPI-Linked Proteins | 1 | 2020 | 472 | 0.040 |
Why?
|
| Mutagenicity Tests | 1 | 2018 | 46 | 0.040 |
Why?
|
| Gene Targeting | 1 | 2021 | 841 | 0.040 |
Why?
|
| Gene Library | 1 | 2021 | 1065 | 0.040 |
Why?
|
| Cell Death | 2 | 2016 | 1676 | 0.040 |
Why?
|
| Fluorescence | 1 | 2020 | 751 | 0.040 |
Why?
|
| Informatics | 2 | 2009 | 72 | 0.040 |
Why?
|
| Bacteria | 1 | 2009 | 2212 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2024 | 2510 | 0.040 |
Why?
|
| Liver | 2 | 2019 | 7571 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2017 | 5860 | 0.040 |
Why?
|
| Phenotype | 4 | 2020 | 16722 | 0.040 |
Why?
|
| Dextran Sulfate | 1 | 2018 | 256 | 0.040 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2013 | 3788 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2007 | 3401 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2023 | 1902 | 0.030 |
Why?
|
| Dopamine | 1 | 2024 | 1581 | 0.030 |
Why?
|
| Administration, Mucosal | 1 | 2016 | 6 | 0.030 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 2 | 2010 | 897 | 0.030 |
Why?
|
| Histidine | 1 | 2018 | 301 | 0.030 |
Why?
|
| Lymphocytes | 2 | 2021 | 2606 | 0.030 |
Why?
|
| Inflammation Mediators | 2 | 2022 | 1889 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 12246 | 0.030 |
Why?
|
| Epithelium | 1 | 2021 | 1606 | 0.030 |
Why?
|
| Interleukin-10 Receptor alpha Subunit | 1 | 2016 | 28 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2021 | 2275 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2015 | 5022 | 0.030 |
Why?
|
| Methane | 1 | 2016 | 44 | 0.030 |
Why?
|
| Bilirubin | 1 | 2018 | 440 | 0.030 |
Why?
|
| Ritonavir | 1 | 2018 | 331 | 0.030 |
Why?
|
| Spermatozoa | 1 | 2020 | 626 | 0.030 |
Why?
|
| Species Specificity | 1 | 2000 | 2413 | 0.030 |
Why?
|
| Caspase 8 | 1 | 2016 | 198 | 0.030 |
Why?
|
| Vaccines | 1 | 2004 | 842 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2018 | 661 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2023 | 2201 | 0.030 |
Why?
|
| Fertility | 1 | 2020 | 770 | 0.030 |
Why?
|
| Protective Agents | 1 | 2016 | 150 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2022 | 1612 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2016 | 367 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2016 | 645 | 0.030 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2016 | 133 | 0.030 |
Why?
|
| Breath Tests | 1 | 2016 | 297 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2021 | 3587 | 0.030 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2015 | 153 | 0.030 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2016 | 299 | 0.030 |
Why?
|
| Mucous Membrane | 1 | 2018 | 659 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 59548 | 0.030 |
Why?
|
| Ribosomal Proteins | 1 | 1997 | 369 | 0.030 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2021 | 951 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2018 | 426 | 0.030 |
Why?
|
| Jurkat Cells | 1 | 2016 | 740 | 0.030 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2015 | 151 | 0.030 |
Why?
|
| Th1-Th2 Balance | 1 | 2014 | 38 | 0.030 |
Why?
|
| Corpus Striatum | 1 | 2020 | 1218 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2015 | 287 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 2015 | 321 | 0.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2017 | 606 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 14653 | 0.030 |
Why?
|
| Spinal Cord Injuries | 1 | 2021 | 927 | 0.030 |
Why?
|
| Anti-Retroviral Agents | 1 | 2023 | 1787 | 0.030 |
Why?
|
| Action Potentials | 1 | 2020 | 1835 | 0.030 |
Why?
|
| Mice, Inbred ICR | 2 | 2004 | 361 | 0.030 |
Why?
|
| Cross-Sectional Studies | 3 | 2020 | 26309 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2003 | 2887 | 0.030 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2012 | 55 | 0.030 |
Why?
|
| Genes, Bacterial | 1 | 2016 | 1076 | 0.030 |
Why?
|
| Adolescent | 5 | 2022 | 88902 | 0.030 |
Why?
|
| Recurrence | 2 | 2015 | 8507 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 1466 | 0.020 |
Why?
|
| Cluster Analysis | 2 | 2009 | 2721 | 0.020 |
Why?
|
| Administration, Oral | 2 | 2011 | 4019 | 0.020 |
Why?
|
| Insulin | 2 | 2007 | 6608 | 0.020 |
Why?
|
| Cross-Priming | 1 | 2012 | 75 | 0.020 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2012 | 511 | 0.020 |
Why?
|
| Receptors, Interleukin-21 | 1 | 2011 | 32 | 0.020 |
Why?
|
| Brain Diseases | 1 | 2021 | 1552 | 0.020 |
Why?
|
| Fas Ligand Protein | 1 | 2012 | 216 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2023 | 3468 | 0.020 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2002 | 1911 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2014 | 54872 | 0.020 |
Why?
|
| Caspase 1 | 1 | 2012 | 227 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2017 | 1505 | 0.020 |
Why?
|
| Radiography | 3 | 2020 | 6968 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2012 | 751 | 0.020 |
Why?
|
| Protozoan Proteins | 1 | 1997 | 843 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2016 | 4349 | 0.020 |
Why?
|
| Solubility | 1 | 2012 | 1078 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 20146 | 0.020 |
Why?
|
| TNF Receptor-Associated Factor 3 | 1 | 2010 | 38 | 0.020 |
Why?
|
| Dementia | 1 | 2024 | 2741 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2012 | 2168 | 0.020 |
Why?
|
| Hydroxycholesterols | 1 | 2009 | 23 | 0.020 |
Why?
|
| Wound Healing | 1 | 2021 | 2800 | 0.020 |
Why?
|
| Clone Cells | 2 | 2004 | 1670 | 0.020 |
Why?
|
| Glucosylceramides | 1 | 2009 | 27 | 0.020 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 2009 | 48 | 0.020 |
Why?
|
| Seasons | 1 | 2015 | 1519 | 0.020 |
Why?
|
| Light | 1 | 2015 | 1358 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2016 | 2093 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2009 | 361 | 0.020 |
Why?
|
| Macrophages, Peritoneal | 1 | 2010 | 244 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2012 | 1751 | 0.020 |
Why?
|
| Brain Injuries | 1 | 2021 | 2053 | 0.020 |
Why?
|
| Mucins | 1 | 2012 | 569 | 0.020 |
Why?
|
| Latent TGF-beta Binding Proteins | 1 | 2008 | 45 | 0.020 |
Why?
|
| Mouth Mucosa | 1 | 2011 | 434 | 0.020 |
Why?
|
| Receptors, CXCR5 | 1 | 2008 | 88 | 0.020 |
Why?
|
| Phylogeny | 1 | 2016 | 2840 | 0.020 |
Why?
|
| Fullerenes | 1 | 2008 | 14 | 0.020 |
Why?
|
| Amino Acid Transport System X-AG | 1 | 2008 | 38 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2012 | 1228 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2000 | 3108 | 0.020 |
Why?
|
| DNA Primers | 1 | 2012 | 2826 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 11062 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2006 | 5888 | 0.020 |
Why?
|
| Toe Joint | 1 | 2007 | 19 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 440 | 0.020 |
Why?
|
| Placenta | 2 | 2009 | 1726 | 0.020 |
Why?
|
| Spinocerebellar Degenerations | 1 | 1987 | 44 | 0.020 |
Why?
|
| Child | 3 | 2014 | 80670 | 0.020 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2008 | 306 | 0.020 |
Why?
|
| Calcium | 1 | 2020 | 5783 | 0.020 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2009 | 453 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2011 | 1716 | 0.020 |
Why?
|
| Antirheumatic Agents | 1 | 2016 | 1383 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 2010 | 592 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2010 | 1337 | 0.020 |
Why?
|
| Software | 1 | 2020 | 4464 | 0.020 |
Why?
|
| Immunization | 2 | 2003 | 1218 | 0.020 |
Why?
|
| Germinal Center | 1 | 2008 | 379 | 0.020 |
Why?
|
| Glucose | 1 | 2017 | 4340 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2009 | 2012 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2010 | 1524 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2006 | 580 | 0.020 |
Why?
|
| Mast Cells | 1 | 2012 | 1405 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2010 | 1266 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 2009 | 1617 | 0.010 |
Why?
|
| Intracranial Embolism and Thrombosis | 2 | 1995 | 143 | 0.010 |
Why?
|
| Contraception, Immunologic | 1 | 2004 | 5 | 0.010 |
Why?
|
| Copulation | 1 | 2004 | 12 | 0.010 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2006 | 415 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2010 | 1526 | 0.010 |
Why?
|
| Incidence | 2 | 2000 | 21527 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 2005 | 612 | 0.010 |
Why?
|
| Concanavalin A | 1 | 2004 | 189 | 0.010 |
Why?
|
| Embryo Loss | 1 | 2004 | 55 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2006 | 3738 | 0.010 |
Why?
|
| Heart | 1 | 1997 | 4425 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2012 | 4860 | 0.010 |
Why?
|
| Neuropeptides | 1 | 2009 | 950 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1997 | 6408 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2008 | 1882 | 0.010 |
Why?
|
| beta-Synuclein | 1 | 2003 | 14 | 0.010 |
Why?
|
| Synucleins | 1 | 2003 | 108 | 0.010 |
Why?
|
| Zymosan | 1 | 2003 | 134 | 0.010 |
Why?
|
| Fibromuscular Dysplasia | 1 | 1983 | 55 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2007 | 1093 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2003 | 411 | 0.010 |
Why?
|
| Prognosis | 2 | 2021 | 29959 | 0.010 |
Why?
|
| Arterial Occlusive Diseases | 2 | 1983 | 742 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 2005 | 921 | 0.010 |
Why?
|
| Cavernous Sinus | 1 | 1983 | 121 | 0.010 |
Why?
|
| Immunization, Passive | 1 | 2004 | 618 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2004 | 547 | 0.010 |
Why?
|
| Joints | 1 | 2003 | 324 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 2003 | 684 | 0.010 |
Why?
|
| Models, Biological | 2 | 2009 | 9464 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3796 | 0.010 |
Why?
|
| Oxidoreductases | 1 | 2003 | 409 | 0.010 |
Why?
|
| Vitamin D | 1 | 2014 | 3270 | 0.010 |
Why?
|
| Hindlimb | 1 | 2003 | 513 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2003 | 928 | 0.010 |
Why?
|
| Mothers | 1 | 2011 | 2208 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2001 | 18076 | 0.010 |
Why?
|
| Streptozocin | 1 | 1999 | 189 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2014 | 5092 | 0.010 |
Why?
|
| Cell Movement | 1 | 2011 | 5204 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 6306 | 0.010 |
Why?
|
| Time Factors | 1 | 2020 | 40149 | 0.010 |
Why?
|
| Algorithms | 2 | 2009 | 14073 | 0.010 |
Why?
|
| Syndrome | 2 | 2001 | 3271 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2004 | 2677 | 0.010 |
Why?
|
| Memory | 1 | 2008 | 2192 | 0.010 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2001 | 520 | 0.010 |
Why?
|
| Maltose-Binding Proteins | 1 | 1997 | 62 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2019 | 81657 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2006 | 3642 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 9613 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2008 | 3139 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5753 | 0.010 |
Why?
|
| Delivery, Obstetric | 1 | 2004 | 949 | 0.010 |
Why?
|
| Carotid Artery Diseases | 1 | 1983 | 872 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 4473 | 0.010 |
Why?
|
| Fetus | 1 | 2004 | 1878 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2009 | 4504 | 0.010 |
Why?
|
| Antibodies, Protozoan | 1 | 1997 | 251 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 1999 | 1156 | 0.010 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 1995 | 72 | 0.010 |
Why?
|
| Skin Diseases | 1 | 1983 | 1084 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 13644 | 0.010 |
Why?
|
| Pregnancy | 2 | 2009 | 30236 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2021 | 65286 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2016 | 42577 | 0.010 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1999 | 1121 | 0.010 |
Why?
|
| Islets of Langerhans | 1 | 1999 | 1350 | 0.010 |
Why?
|
| Body Weight | 1 | 2004 | 4626 | 0.010 |
Why?
|
| Intracranial Aneurysm | 1 | 1983 | 1271 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2008 | 9358 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2004 | 2971 | 0.010 |
Why?
|
| Death Certificates | 1 | 1993 | 172 | 0.010 |
Why?
|
| Spain | 1 | 1993 | 483 | 0.010 |
Why?
|
| Mutation | 1 | 2016 | 30214 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2003 | 3440 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 1995 | 1055 | 0.010 |
Why?
|
| Cerebral Angiography | 1 | 1995 | 1263 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 15912 | 0.010 |
Why?
|
| Olivopontocerebellar Atrophies | 1 | 1987 | 19 | 0.000 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1999 | 3408 | 0.000 |
Why?
|
| Cerebral Ventricles | 1 | 1987 | 550 | 0.000 |
Why?
|
| Myocardium | 1 | 1997 | 4765 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1987 | 20710 | 0.000 |
Why?
|
| Brain Stem | 1 | 1987 | 858 | 0.000 |
Why?
|
| Carotid Artery, Internal | 1 | 1983 | 440 | 0.000 |
Why?
|
| Cerebellum | 1 | 1987 | 1520 | 0.000 |
Why?
|
| Registries | 1 | 1993 | 8352 | 0.000 |
Why?
|
| Alcoholism | 1 | 1987 | 1980 | 0.000 |
Why?
|
| Hypertension | 1 | 1995 | 8616 | 0.000 |
Why?
|
| Brain Ischemia | 1 | 1983 | 3001 | 0.000 |
Why?
|